Skip to main content
Premium Trial:

Request an Annual Quote

SNPs Pink Slips at DNA Sciences

Premium

DNA Sciences’ recent staff changes suggest a directional shift from traditional genomics to developing and commercializing diagnostic and drug-discovery products. The company fired chairman and CEO Hugh Reinhoff, whose position was assumed by former chief business officer Steve Lehrer. Suffering from what observers noted as a high cash burn rate, the company will also lay off roughly half of its 175-member workforce, according to a spokeswoman, who adds that most of the personnel cuts would be at the Fremont, Calif., headquarters.

“We will continue to pursue the commercial opportunities through our DNA Sciences Laboratories business, and the pharmaco-genetic research activities that the company undertakes,” the spokeswoman says. In fact, DNA Sciences Laboratories, formerly known as PPGx, is expected to increase its staff size by 25 percent within the next few months. The division focuses on genotyping, target validation, and SNP discovery.

— Kirell Lakhman

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.